Moderna (NASDAQ:MRNA) saw its shares rose nearly 5% in premarket trading Monday after the U.S. Food and Drug Administration (FDA) has approved the drugmaker’s next-generation COVID-19 vaccine, ...

U.S. stock futures are lower with all eyes on key economic data, tax legislation and tariffs. Not only will investors follow ...

The number of mortgages approved by UK lenders for home purchases dropped more than anticipated in April as the end of a tax ...